新聞稿 即時發佈 【中國香港— 2026年3月31日】 — 比幹生物有限公司（比幹生物）、InnoHK 病毒與疫苗研究中心（CVVT）、深圳華大智造科技股份有限公司（華大智造）以及臨床腫瘤學合作夥伴鄺麗雲教授今日宣布策略性合作，並成立 PDOHub™ HK ，即 亞洲首個整合式類器官精準醫學中心 。這項策略性合作結合前沿類器官技術、自動化系統及臨床專業知識，旨在加速精準醫學發展、輔助臨床決策，並推動腫瘤學及傳染病領域的轉化研究。 亞洲首個整合式 PDOHub™ HK 該策略性合作協議體現各方共同致力於建立及發展一個專注於患者來源類器官（PDO）技術的中心，以推進多個疾病領域的精準醫學、臨床決策及轉化研究。PDOHub™ HK（以下簡稱 PDOHub）將作為開發及擴展類器官應用技術的核心樞紐，連接前沿科學與臨床實踐。透過提供患者個性化的深度見解，該計劃賦能研究人員和醫療合作夥伴，加速在傳染病、腫瘤和其他新興健康挑戰領域的發現並完善治療策略，從而使PDOHub成為亞洲領先的類器官驅動型精準醫療中心。 近十年類器官科研為 PDOHub™ HK 奠

PRESS RELEASE FOR IMMEDIATE RELEASE HONG KONG, China, 31 March 2026 – BiomOrgan Limited (BiomOrgan), InnoHK Centre for Virology, Vaccinology, and Therapeutics (CVVT), MGI Tech Co., Ltd. (MGI), and clinical oncology partner Professor Dora Kwong today announced the strategic collaboration and the establishment of PDOHub™ HK, Asia’s first integrated Organoid-Based Precision Medicine Centre . This strategic collaboration harnesses cutting-edge organoid technology, automation,

We are incredibly proud to announce that the InnoHK Centre for Virology, Vaccinology, and Therapeutics (InnoHK CVVT) has been awarded five medals at the 51st International Exhibition of Inventions Geneva for our advancements in biomedicine and biotechnology. From March 11th to 15th, CVVT made its mark on the global stage, sending five teams to the International Exhibition of Inventions Geneva 2026. They joined over 1,000 innovations from more than 40 countries, showcasing the

HK Research Delivers Tangible Patient Benefits Strategic Alliance with Anitch and Watsons HK Empowers the Local Community Propels HK Science to the Global Stage - Redefining Eczema Care for a New Era [Hong Kong — February 12, 2026] Eczema (Atopic Dermatitis) remains one of Hong Kong’s most persistent health challenges, affecting one in five residents. For decades, hundreds of thousands of patients have been trapped in a gruelling cycle of inflammation, itching, and drug depen

CVVT is proud to announce that ten of its distinguished researchers have been recognised as Highly Cited Researchers 2025 by Clarivate. This prestigious honour highlights their exceptional contributions to the fields of microbiology and infectious diseases, reflected in the remarkable influence and high citation impact of their research. According to Clarivate, a total of 6,868 scholars from 60 countries and regions have been named Highly Cited Researchers in 2025. The recogn

Researchers from the InnoHK Centre for Virology, Vaccinology and Therapeutics (CVVT) and the Department of Microbiology, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), in collaboration with Sichuan University, have discovered a powerful bispecific inhibitor capable of combating all existing human-pathogenic coronaviruses, including those resistant to existing treatments like Paxlovid. This promising inhibitor, named TMP1, offers

Join the Centre for Virology, Vaccinology, and Therapeutics (CVVT) as we unveil cutting-edge advancements in influenza vaccines, liver...

A collaborative research team from CVVT and the Department of Microbiology at the School of Clinical Medicine within the LKS Faculty of...

Two distinguished scholars from CVVT have been honored among the top 100 global researchers in Microbiology by Research.com in its 2025...

InnoHK Centre for Virology, Vaccinology, and Therapeutics (InnoHK CVVT) has achieved remarkable success at the prestigious 50th...

The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Centre for Virology,...

A research team led by Professor Jane Zhou Jie and Professor Yuen Kwok-Yung, from InnoHK CVVT and the Department of Microbiology under...

CVVT proudly announces that ten of its distinguished researchers have been honored as "Highly Cited Researchers 2024" by Clarivate. This...

In the 2024 Best Scientists Rankings by Research.com , Professor Kwok-Yung Yuen , our Managing Director at CVVT, has been recognized as...

CVVT proudly announces its outstanding success at the 49th International Exhibition of Inventions in Geneva, securing a remarkable total...

CVVT proudly announces that eleven of its esteemed researchers have been recognized as "Highly Cited Researchers 2023" by Clarivate, in...

Dr. Yuan Shuofeng, a principal investigator of CVVT and an Assistant Professor in the Department of Microbiology at the LKS Faculty of...

In the 2023 Best Scientists Rankings by Research.com, Professor Kwok-Yung Yuen, our Managing Director at CVVT, has been recognized as one...

Our research team participated in the 48th International Exhibition of Inventions of Geneva. Led by Dr. Jane Zhou and Dr. Raven Kok, we...

A research team led by Dr Zhou Jie and Professor Yuen Kwok-yung from CVVT and the State Key Laboratory for Emerging Infectious Diseases...